Deep Track Capital, LP - Mar 19, 2025 Form SCHEDULE 13G Schedule Report for Immunovant Inc. (IMVT)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Immunovant Inc. Common Stock, $0.0001 par value per share
Symbol
IMVT
Shares outstanding
170M shares
Disclosed Ownership
9.5M shares
Ownership
5.59%
Form type
SCHEDULE 13G
Date filed
3/26/2025, 04:09 PM
Date of event
Mar 19, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 5.59% 9.5M 0 9.5M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.59% 9.5M 0 9.5M /s/ David Kroin David Kroin, Director
David Kroin 5.59% 9.5M 0 9.5M /s/ David Kroin David Kroin